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The  proliferative  capacity of somatic  cells has  been a  fundamental  issue  in 
biology. About  70  years ago,  studies  by Carrel  (I) and  Ebeling  (2) convinced 
most  biologists  that  normal  somatic  cells  could  have  unlimited  proliferative 
abilities.  However,  studies  of fibroblast  cultures  over the  past  20  years  have 
reversed that  opinion  (3-6).  The  modern  work has been characterized  by two 
general  findings:  The  cells studied  fail  to proliferate  indefinitely in  vitro,  and 
the proliferative capacity declines as the age of the cell donor increases.  By far 
the largest change with age is the reduction in proliferative capacity when cells 
from fetal tissues are compared with cells from adults (3-6). 
Even if normal somatic cells are unable to proliferate indefinitely in vitro, it is 
crit;.cal  to determine  how they behave in  vivo.  The  earliest  precursor  cells or 
stem  cells  that  populate  the  hemopoietic  and  lymphoid  systems  (7-10)  must 
proliferate  extensively to perform  their  normal  functions.  Their  proliferative 
capacity may be unlimited  because their  long-term functional abilities may not 
decline with age (11-19).  However, declines may occur with age, especially in 
lymphoid precursor cells (20-26). An explanation  for this disagreement may be 
that the ratios of precursor cell types change with age (18, 27-29).  Reports that 
fetal stem cells have higher long-term repopulating abilities than stem cells from 
adults  (30-32)  are  important  evidence  that  their  proliferative  capacities  are 
limited.  However, our initial  results suggested that  marrow cells from old and 
young adults have long-term repopulating abilities similar to those of fetal liver 
cells (18). 
In  the  present  report,  we  measured  repopulating  abilities  of erythropoietic 
stem cells by competitive repopulation. Equal numbers of cells from fetal, young, 
or old donors were mixed with a standard dose of pooled marrow with genetically 
distinguishable hemoglobin, This standard dose is called the competitor marrow. 
The cell mixtures were injected intravenously into stem cell-deficient hosts. The 
percentage of hemoglobin produced by each donor indicated its functional ability 
(17, 18, 33). 
Competitive repopulation has proved to be sensitive in detecting small changes 
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in long-term repopulating abilities (13,  15,  17,  18, 34-36). In the present study, 
we also gave the recipients repeated doses of sublethal irradiation.  This should 
greatly increase the sensitivity, because each irradiation greatly reduces the long- 
term repopulating activity (17,  18). A high level of proliferation is thus required 
from  the  surviving  stem  cells,  and  this  should  bring  out  any  subtle  defects 
intrinsic  to them.  After two or three serial  irradiations and  300-400  d,  equal 
numbers of cells from old adult marrows repopulated at least as well as cells from 
young marrows or even those from  15- or  16-d fetal livers. The least complex 
explanations for these results are that the earliest erythropoietic precursors (a) 
do  not  have  intrinsic  limitations  on  their  proliferative  capacities,  and  (b)  are 
present at no greater concentrations in fetal liver than in adult marrow. 
Materials and Methods 
Mice.  C57BL/6J (B6)  mice and their F1  hybrid with WB/ReJ (WBB6F1) were bred 
and maintained at The Jackson Laboratory, which is fully accredited by the American 
Association for Accreditation of Laboratory Animal Care. All mice used, including aged 
animals, appeared healthy; they had no signs  of leukemia-like cancers on gross autopsy 
(enlarged spleen, lymph nodes, or thymus) and white cell numbers were normal. The 
aging colony has been fully described (37). WB-W/+  ×  B6-W~/+  crosses were made to 
produce W[W , W]+, W°/+, and +/+ offspring. The W/W  ~ mice are genetically anemic 
mutants with defective primitive stem cells so that they are repopulated by donor stem 
cells  without further treatment (38).  Heterozygous W/+ or W~]+  mice are essentially 
normal hematologically; before being used as recipients, they or +/+ (normal) mice were 
lethally irradiated with  1,100-1,200  (usually  1,200)  rad  in  a  137Cs gamma  irradiator 
(Shepherd Mark I; J. L. Shepherd & Associates,  Glendale, CA) at a dose rate of 220 tad/ 
min  15-18 h  before the marrow was  transplanted. Sublethal irradiation (500 rad) was 
given using the same machine and dose rate. Some of the recipients were also thymecto- 
mized at 4-6 wk of age by sucking the thymus from the thoracic cavity into a glass pipette 
and rapidly closing the  incision.  In  the  six experiments described in Tables I-III, all 
recipients were males and were 3-6 mo old when the radiation and cell transplantation 
was  performed.  All  recipients  were  within  1  mo  of the  same  age  in  the  individual 
experiments. Stem cell donors were also males (B6 +/+ or WBB6F1 +/+). 
Stem Cell Transplantation.  Marrow cell suspensions were prepared using femurs and 
tibias from each  donor.  The bones were  cleaned,  the  ends opened, and  the  marrow 
washed out by vigorous and repeated flushing of balanced salt solution (Hepes buffered 
to a pH of 7.4 as described in reference 17) through a  23 gauge needle. Entire livers 
from fetal mice were minced lightly with ground glass tissue homogenizers. Clumps of 
cells were dissociated by forcing them through a  I ml plastic syringe pressed against the 
bottom of a 4 ml culture tube. Stroma was filtered out with 100-mesh nylon cloth (18). 
Nucleated cells were counted using a Coulter model ZBI Electronic Cell Counter (Coulter 
Electronics, Inc., Hialeah, FL), after erythrocytes were lysed using standard iysing agents 
for white cell counting: Zap Isoton or Zap-ogiobin (Coulter Electronics, Inc.) or Ultra- 
lyse (Clay Adams,  Parsippany, N  J). Cells were injected intravenously through 26-gauge 
needles into the lateral tail veins of warmed mice, usually between 9:00 and 11:30 A.M. 
Competitive Repopulation Assay  for Erythropoietic Stem Cells.  This assay was used because 
the traditional macroscopic spleen colony assay is not proportional to long-term repopu- 
lation, the actual function of the earliest precursor cells. Spleen colony numbers are much 
too high for the repopulation ability of transplanted marrow (16, 17) or circulating white 
cells (34) compared with fresh marrow, while they are much too low in fetal liver (31). 
Therefore we measured repopulating ability directly. 
The technique used is based on the fact that B6 mice have c~,/32  ~  (s, single) hemoglobin, 
which forms the band migrating furthest on the cellulose acetate gels used, whereas WB 
dmaj  dram  mice have a2f12  " and a2f12  (d, diffuse) hemoglobins. These are the intermediate- and 
slowest-migrating bands, respectively, with 80 and 20% of the d  type hemoglobin. The z 
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FIGURE  1.  95%  confidence limits (shaded  area)  of the linear  regression  for the data in a 
single experiment. The open points are mean values for this experiment at 60 and 120 d, with 
bars giving the standard error (SE); the number of recipients tested is given beside each point. 
These data were also used to calculate the correlation coefficient: r = 0.951, with T =  15.96 
and 27 degrees of freedom, so that the correlation is significant  (P <  0.001).  Donors and 
competitors were 3-5 mo old B6 and WBB6F] +/+ females, respectively. The recipients were 
4-5-too-old lethally irradiated WBB6F, +/+ females. The shaded points and bars, plotted at 
a 2:1 ratio of B6 to Fi, show mean and SE values in a different experiment with three lethally 
irradiated female WBB6F~ recipients checked at 66, 195, and 290 d. Each received 5.4 x  106 
B6 + 2.7 ×  10  ~ WBB6FI +/+ marrow (M) cells. 
WBB6F]  hybrid  mice  have  50%  of each  hemoglobin  type:  three  bands  with  the  s 
comprising 50% and two d  bands comprising 40 and  10% of the total hemoglobin. The 
bands  are  quantitatively  separable  by standard  electrophoretic  methods  (39),  and  the 
percentages  of the  B6 and  WBB6F1  types are  calculated from the percentage of the  s 
type, as previously illustrated (33). To determine long-term repopulating abilities, B6 and 
WBB6F]  cells are  mixed and  given  to WBB6F~  recipients  whose stem cells have been 
depleted (33). There is little or no hybrid resistance from WBB6FI mice against B6 cells 
(35), and the marrow cell number used, I ×  106 WBB6Fl +/+ plus 2.5 ×  106 B6, produce 
roughly similar amounts of hemoglobin of each type over the  lifespan of the recipient 
(17,  18, 33, 35). 
Fig.  1 illustrates  the competitive repopulation assay, giving the relationship  between 
the number of donor cells and the percentage of donor hemoglobin in the recipients after 
2 and 4 too. Each dose of the B6 donor cells was mixed with a constant dose of WBB6F, 
competitor cells and injected intravenously into a recipient. The shaded area shows 95% 
confidence  limits  for a  linear  regression.  Values  at  60  and  120  d  are  shown  as  open 
symbols; they were  pooled in  the  calculated  regression  because  there  is  no systematic 
change with time. This is also illustrated by the solid symbols from a separate experiment 
in which similar results were found at 66,  195, and 290 d (Fig.  1). 
The competitive repopulation technique is extremely sensitive at detecting disparities 
in long-term stem cell functions between a  series of donors whose cells are each mixed 
with a  single competitor pool. Differences between experiments  (33) may occur for the 
same reason: the competition between two cell types to repopulate a recipient magnifies 
small and even random differences in the repopulating capacities of the cell populations 
used. 
The sensitivity of the assay is illustrated  by the effects of transplantation  (15,  17, 36). 
For example, recipients of 3 ×  106 WBB6F~ cells and 7.5 ×  106 B6 cells had 51  -+ 6% F] 
hemoglobin, while previously transplanted F] ceils totally failed to compete, producing 0 
_+ 3% donor hemoglobin. This showed at least a 20-fold reduction in repopulating ability 762  REPOPULATING  ABILITIES  OF  FETAL  AND  ADULT  CELLS 
as the result of a  single transplantation,  although  107 cells  had been transplanted and 
given 4 mo to recover (17).  Such a single transplantation causes little or no reduction in 
macroscopic spleen colony concentrations (15) and only a twofold reduction in their self- 
renewal (numbers of colonies per colony) (36).  The sensitivity of the assay is also shown 
by the 20-fold reduction in erythropoietic, competitive repopulating abilities 90 d after 
mice recovered from 550 rad sublethal irradiation (17). 
In the experiments described in Tables I-III, suspensions of stem cells were prepared 
from individual old, young, or fetal donors. A pool of cells was prepared from young 
mice of the  competitor genotype.  B6  mice  were  used  as  donors  with  WBB6Ft  +/+ 
competitors, and vice versa. Cells from each donor were mixed with a constant number 
of cells from the same competitor pool. These mixtures were injected intravenously into 
four to six lethally irradiated or W/W  ~  recipients of the W BB6F1 genotype. The percentage 
of donor hemoglobin in each recipient measured the long-term repopulating ability of 
the  donor's  erythropoietic stem  cells.  The  recipient hemoglobins are  not  completely 
replaced by donor cells for 50-60 d, so levels of circulating hemoglobins were sampled 
75-103 d after the initial transplantation. Then the same recipients were irradiated with 
500 rad to require additional rounds of competition repopulation. Blood samples were 
taken 75-178 d after each sublethal irradiation. 
Hemoglobin Synthesis by Reticulocytes.  Peripheral blood was collected from the retroor- 
bital sinuses,  30 ttl per mouse in heparinized 10-#1 and 20-ttl capillary tubes. The  10-/zl 
sample was used to determine hemoglobin concentrations and the 20-td sample was added 
to 100 td of F-12M medium (12-615A; M. A. Bioproducts, Walkersville, MD) containing 
2% fetal calf serum and  50 ttCi  of 25S-labeled methionine (S.J.-204; Amersham Corp., 
Arlington  Heights,  IL)  to  label  freshly  synthesized  hemoglobin  (40).  Cultures  were 
incubated for 3 h at 37°C in 5% carbon dioxide, 95% air. The blood cells were washed 
twice with cold saline by centrifugation and the pellet was resuspended in 20 ttl of the 
cystamine lysing agent (39)  used to prepare hemoglobins for electrophoresis. Samples 
were frozen to lyse the cells and the hemoglobin types were separated by electrophoresis 
on cellulose acetate as previously described (39). Each of the hemoglobin-containing bands 
was cut from the cleared cellulose acetate gel, solubilized in  1 ml of Soluene-350 (No. 
6003038 diluted 9:1  with distilled water; Packard Instrument Co., Downers Grove, IL), 
and the ssS activity was counted by scintillation counting with an Omniflor cocktail (NEF- 
906B; New England Nuclear, Boston, MA).  Background was determined by counting a 
portion of the gel beyond where the hemoglobin migrated, and background counts were 
subtracted. Data was expressed as the fraction d/d + s: (counts in the two diffuse bands)/ 
(total counts in  the  diffuse +  single bands).  Two allophenic mice were used  in  these 
experiments; they had been prepared by Dr. Peter Hoppe using standard procedures (41) 
to fuse a B6 embryo with a CBA/HT6 embryo. The latter has diffuse hemoglobin, while 
B6 mice have single hemoglobin. 
Results 
Competitive  Repopulation: Fetal Liver, Old Marrow, and Young Marrow.  When 
we first analyzed the hemoglobins, marrow from old B6 donors competed best, 
while young B6 marrow or 15-d fetal liver donors gave similar results (Table I, 
first  column).  Cells  from  each  had  been  mixed  with  equal  doses  of WBB6F1 
competitor  cells.  After  the  first  dose  of  500  tad,  the  percentage  of  donor 
hemoglobin from the fetal liver cells was reduced twofold and was significantly 
lower than percentages from old or young marrow cells (Table I, second column). 
This did not change after the second dose of 500 rad, although the percentage 
from young adult marrow increased (Table I, third column). 
When genotypes were reversed, using fetal, young, and old WBB6F1 donors 
and  a  pool  of  B6  competitors,  fetal  cells  gave  the  highest  levels  of  donor 
hemoglobin initially and remained highest after the first 500 rad of irradiation 
(Table  II,  first  and  second  columns);  however,  these  differences  were  not HARRISON,  ASTLE,  AND  LERNER 
TABLE  I 
Competitive Repopulating Ability of B6 Donors in Lethally Irradiated 
WBB6F t Recipients 
763 
Percentage donor hemoglobin after: 
Donor age, 
tissue  80 d,  101 d  500 rad; 186 d,  500 Fad; 348 d, 
2O7 d  369 d 
Old marrow  84 ±  5 (8)*  63 ±  7 (8)  65 ±  12 (7) 
Young marrow  59±8(8)  49__.  10(7)  69+  11 (6) 
Fetal liver  53 +  3 (7)  21 _+  3 (7)*  26 ±  6 (4)* 
Table  I  summarizes  two  experiments  with  B6  male  donors  of  the 
following ages: Fetal liver,  15 d  after vaginal plug observed in mother; 
young marrow,  3-4 mo; old marrow, 24-30 mo. All data are mean + 
SE (n). The total cell numbers collected from the livers of each fetal 
donor averaged 3.0 +  0.4 x  107 (7); from the femurs and tibias of each 
young donor, 7.0 +  0.4 x  107 (8); and from each old donor, 8.6 +  0.4 
x  10' (8). For each donor, 2.5 x  106 cells were mixed with 1.0 x  106 
marrow cells from the same pool of WBB6F1 +/+ competitors. These 
mixtures were injected intravenously into lethally irradiated recipients 
and their hemoglobins were checked after 80 or 101 d. They were given 
500 rad 29 or 31  d  later and the hemoglobins were checked a  second 
time 75  or  77  d  after the irradiation. A  second dose of 500 tad was 
given 271 or 292 d after the beginning of the experiment, and the third 
hemoglobin analysis was done 76 or 77 d later. The number of recipients 
per donor at the first two hemoglobin checks averaged 3.4 and 3.3, and 
was 2.3 by the last one. 
* Values are significantly different from others in the same column (P < 
0.05 by the Student-Newman-Keuls multiple range test). 
TABLE  II 
Competitive Repopulating Ability of WBB6FI Donors in Lethally 
Irradiated WBB6F I Recipients 
Donor age, 
tissue 
Percentage donor hemoglobin after: 
75 d,  103 d  500 rad; 180 d,  500 rad; 385 d, 
208 d  413 d 
Old marrow  33 +  12 (6)  37 _  13 (6)  33 ±  19 (4) 
Young marrow  25+  7(6)  37±  7(6)  41_17(5) 
Fetal liver  50 ±  10 (6)  53 +  9 (6)  35 _  12 (3) 
Table II summarizes two experiments with WBB6F~ +/+ male donors of 
the following ages: fetal liver, 16 d; young marrow, 7-8 mo; old marrow, 
23-28  too.  The  total  cell  numbers  [mean  +  SE  (number of donors)] 
collected from the liver of each fetal donor averaged  12.4 _+ 0.8 x  10" 
(6); from the femurs and tibias of each young donor, 11.6 +  0.6 x  107 (6); 
and from each old donor,  13.0 +  0.6 x  10/(6). For each donor, 1 x  106 
cells were mixed with 2.5  x  106 marrow cells from the same pool of B6 
competitors. The mixtures were injected intravenously in lethally irradi- 
ated recipients, whose hemoglobins were checked after 75 or 103 d. They 
received 500 rad 8 d later, and hemoglobins were checked 97 d after that. 
The second dose of 500 tad was given in 27 d, and the hemoglobins were 
last checked 178 d later, 385 or 413 d after the experiment began. Seven 
recipients were given only the 2.5  X  10  ~ B6 competitor cells. They had 
only B6 hemoglobin throughout the experiment.  Other details are the 
same as in Table I, except that the number of recipients used for each 
donor averaged 2.2 at the last hemoglobin analysis. 764  REPOPULATING ABILITIES OF  FETAL AND ADULT CELLS 
significant by the Student-Newman-Keuls test. After the second irradiation, the 
percentages of donor hemoglobin from the fetal liver donors dropped to those 
from the young and old marrow donors (Table II, third column). 
The failure to demonstrate differences does not prove similarity. However, 
the important point in Tables I and II is that stem cells from fetal donors did 
not develop increasing advantages over stem cells from adult donors during the 
rigorous treatments of transplantation,  two doses of sublethal irradiation, and 
the long time periods used. This comparison of stem cells over the range from 
15 d fetal life to 30 mo of age showed very minor changes compared with those 
caused by a single transplantation or sublethal irradiation (17). 
The differences in the results given in Tables I and II are not explained by 
the recovery of WBB6FI recipient cells in the experiments summarized by Table 
II.  In  each  of these experiments,  control  recipients  were given  only the  B6 
competitor cells and all had 98-100%  B6 hemoglobin at all hemoglobin deter- 
minations. Another explanation for these differences is that the adult B6 marrow 
donors described in Table I had graft vs. host-responsive cells that damaged the 
repopulating ability of the WBB6F~ competitor marrow. The experiments in the 
following section were performed to test this. 
Use  of Immunologically  Crippled  and  Unirradiated  Recipients.  Two  types of 
recipients were used in  this experiment:  immunologically crippled,  thymecto- 
mized, irradiated recipients (Table III, top 3 lines) and immunologically intact 
W/W  v recipients (Table III, bottom 3 lines). The W/W  v recipients provided an 
unirradiated environment for the stem cells and prevented damaging graft vs. 
host  reactions  from  B6  against  WBB6F1  antigens  (42).  In  addition  to  these 
results,  12-d fetal liver donors were used in one of the experiments in this set. 
These failed to produce any donor hemoglobin in three immunologically  crippled 
and two W/W  v recipients that were followed for 307 d. Liver cells from 15-16- 
d fetal donors gave intermediate hemoglobin percentages, lower than old marrow 
donors  but  higher  than  young marrow  donors  when hemoglobins were first 
analyzed (Table  III,  first  column).  This  pattern  was  not  altered  by  the  first 
treatment of 500 rad, but, after the second or third treatments, fetal liver cells 
produced the lowest amounts of donor hemoglobin (Table III, third and fourth 
columns). Marrow cells from old donors consistently produced the highest levels 
of donor hemoblogin in these experiments but they were not significantly higher 
than the levels produced by fetal cells. 
These are similar to  the initial  results with the same genotypes except that 
young cells gave higher values in  Table  I.  Again,  the important point is  that 
there was no loss in the proliferative capacity of erythropoietic stem cells between 
the 15th d of fetal development and the end of the adult lifespan. One explana- 
tion for this is the clonai selection hypothesis. It predicts that most stem cells do 
not proliferate and that differentiated cells are produced by a small fraction of 
the stem cells that cycle and use up their proliferative capacity one, or a few, at 
a time (43-46). The experiment described in the following section was performed 
to test this. 
Numbers of Stem Cells Producing Erythrocytes.  Tetraparental mice were made 
by fusing embryos of two different inbred stains  at an early preimplantation 
stage (41). Such mice have cells of both parent strains in their tissues. We studied HARRISON,  ASTLE,  AND  LERNER  765 
TABLE  III 
Competitive Repopulating Ability of B6 Donors in Immunologically  Crippled or Intact W/I/W 
WBB6F  j Recipients 
Percentage donor hemoglobin after: 
Donor age, tissue  500 rad; 193 d,  500 rad; 298 d,  500 rad; 465 d, 
83 d, 98 d  196 d  307 d  495 d 
In thymectomized,  lethally irradiated recipients: 
Old marrow  75 + 8 (6)  70 ±  10 (5)  71 ±  13 (5) 
Young marrow  30 + 4 (5)*  30 -  7 (5)*  45 +  9 (5) 
Fetal liver  55±6(2)  43±  1 (2)  32± 13(2) 
B 
m 
m 
In untreated W/W  ~ recipients: 
Old marrow  52+3(6)  57+  4(6)  66+  8(6)  59+12(5) 
Young marrow  31+5(5)*  28---  5(5)*  42+11(5)  42+  7(5) 
Fetal liver  43+2(2)  44+  9(2)  41+  2(2)  24± 13 (2) 
Table III summarizes two experiments with B6 male donors of the following ages: fetal liver, 15- 
16 d; young marrow, 4-5 mo; and old marrow, 25-26 mo. Total cell numbers collected from the 
liver of each fetal donor averaged 8.6 _  4.2 x  107 (2) while the femurs and tibias from each young 
donor averaged  6.8 + 0.4 x  10 7 (5) and those from each old donor averaged  7.5 ± 0.4 x  107 (6). 
For each donor, 2.5 x  108 cells were mixed with 1.0 x  108 cells from a pool of WBB6F~ marrow. 
These  mixtures were  injected intravenously into lethally  irradiated recipients  that  had  been 
thymectomized  at 4-6 wk of age or into untreated W/W  ~ recipients.  The same donors and cell 
mixtures were  used in both types of recipients  in each experiment. Hemoglobins were checked 
initially after 83 or 98 d and the first dose of 500 rad was given 7 or 9 d later. Hemoglobins were 
checked the second time 91 or 101 d after that and the second dose ofS00 rad was given 14 or 33 
d later. Hemoglobins were checked for the third time after a total of 298 or 307 d; the third dose 
of 500 rad was given at 381 or 411 d (by this time only W/W  ~ recipients survived), and hemoglobins 
were checked for the fourth time 84 d later. Other details are the same as Table I except that the 
numbers of recipients at the first hemoglobin  check averaged 4.8 and 4.4; at the second hemoglobin 
check, 4.2 and 3.8; and at the third hemoglobin check, 2.3 and 3.0 for the recipients in the top 
and bottom three lines, respectively. At the fourth hemoglobin check, numbers of W/W  ~ recipients 
averaged 2.6 per donor. 
* Values are significantly different from only the higher of the other two values in each half-column 
(P < 0.05 by the Student-Newman-Keuls  multiple range test). 
hemoglobin production in vitro from blood samples of two  tetraparental mice 
made from the B6 and CBA/HT6  strains. Stem cells in such mice will produce 
either  s  or  d  hemoglobin. 3~S-labeled methionine was  incorporated  into  20-#1 
blood  samples  during  3  h  in  vitro.  Only reticulocytes,  the  erythrocytes  most 
recently  released  into  the  blood  stream,  synthesize  hemoglobin,  so  labeled 
hemoglobins were made by a  cohort of erythrocytes produced during the past 3 
d  at most. 
Fig. 2  shows the fractions of 35S counts in d  type hemoglobins (d/d+  s) from 
two tetraparentai mice measured at 3-d intervals over 30 d. Measurements made 
on a  normal F~  hybrid mouse and a  B6  mouse are  also shown as controls.  In 
mean +  SE (n), the fractions for T1  were 0.091  _  0.011  (11); for T2, 0.117  + 
0.009  (10);  and  for  the  F~  control,  0.499  +  0.011  (7).  Using  the  binomial 
distribution, the number  of active stem cells during a  single 3-d period can be 
calculated as: N  =  [p (1  -  p]/s 2,  where p  is the fraction of the "cLvpe, and s 2 is 
the variance of independent samples (45,  47).  With s  =  SEX  ~¢n, for T1, s  = 
0.011  x  ~  and, with p  =  0.091, N  =  62; for T2, s  =  0.009  X  ~  and, with 
p=0.117,  N=128. 766  REPOPULATING  ABILITIES  OF  FETAL  AND  ADULT  CELLS 
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FIGURE 2.  The fraction of[S~S]methionine-labeled (S-35 meth) diffuse (d), of the total diffuse 
+  single (d +  s) hemoglobin bands (Hb) from cellulose acetate gels, from repeated samples at 
3-d intervals. The WBB6FI  control showed a  fraction of ~0.50 as expected, while the two 
tetraparental mice (T1 and T2) made by joining early B6 and CBA/H-T6 embryos, averaged 
-0.10.  Their total hemoglobins measured earlier gave the following d/d +  s fractions: (T1) 
0.16, 0.14, and 0.07 at 50, 123, and  183 d of age; (T2) 0.21 and 0.10 at 82 and 142 d of age. 
T1 was  199 d old and T2  156 d old at day 0. 
The number of active stem cells is surely higher than 62 or  128, because it 
declines as s increases. The calculated values of s are too large since they include 
all sources of variability, not only that due to small numbers of active stem cells. 
The value of the F1 hybrid (s =  0.011  X ,Jff) is similar to the values in tetrapa- 
rental mice. Since the FI hybrid has only one type of stem cell, this suggests that 
little or none of the variance results from limited numbers of active stem cells. 
In two determinations using B6 blood, the fractions were 0.023 and 0.04 instead 
of 0.  This suggests that one source of variability was the labeled material left 
behind the fastest-migrating s band, amounting to 2-4%  of its activity. Other 
sources of variability may be minor levels of contamination in the hemoglobin 
bands with other labeled proteins, irregularities in the gel, and counting errors. 
Discussion 
Our results contradict previous reports (30-32)  that equal numbers of fetal 
liver cells have higher repopulating abilities than adult marrow cells.  In two of 
these cases, CBA mouse strains were used. Different strains may give different 
results, as shown by Tables I and II in this report.  Furthermore, in two cases, 
erythropoietic repopulation was not specifically studied, because chromosome 
markers were used without identifying the cell types proliferating (30,  31).  In 
the third case, adult marrow cells failed to compete as well as fetal liver cells in 
the environment of an  11-d fetus (32).  This fits with our finding that cells from 
12-d  fetal  livers  failed  to  compete  in  repopulating adult  donors,  if the  fetal 
hemopoietic environment at 12 d and earlier differed so much from the adult in 
marrow environment that stem cells from one grew less well in the other. 
Our competitive repopulation assay should rigorously measure the long-term 
functional capacity of erythropoietic stem cells,  because small declines in prolif- 
erative ability are magnified when two populations of genetically distinguishable HARRISON,  ASTLE,  AND  LERNER  767 
stem cells compete in repopulating the recipients (Fig.  1 and references 17,  18, 
33). However, requiring the cell mixtures to repeatedly recover from sublethal 
irradiation should greatly enhance the sensitivity to stem cell defects, because 
irradiation greatly stresses stem cells (17,  18). A single dose of 560 rad reduced 
repopulating  activity  300-500-fold  when  the  erythropoietic  competitive  re- 
populating abilities of WBB6F1  +/+ recipient type cells were measured 125  d 
after sublethal irradiation and the injection of 2.5  ×  10 6  B6 competitor cells. 
The recipient's own cells in mice given 560 rad were equivalent in repopulating 
ability to 0.73-1.2  x  106 (95%  confidence limits) fresh WBB6F1  +/+ marrow 
cells  tested  in  the  same  experiment.  Since  adult  mice  have  300-500  x  10 n 
marrow cells,  this  represents a  300-500-fold  reduction in  effective stem  cell 
numbers. 
The surviving descendants of the cells in each mixture must compete to again 
repopulate recipients after each dose of irradiation. Since these stem cells are in 
the  same  recipient  and  are  exposed  to  exactly the  same  stresses,  only  their 
intrinsic differences in  repopulating ability and radioresistance will  affect the 
outcome. After 75-103 d in the recipient, the levels of radioresistance probably 
are similar for early erythropoietic stem cells descended from fetal liver or adult 
marrow. Survivors should therefore be determined at random, and even small 
declines of proliferative ability should be greatly magnified as the different cell 
types compete to repopulate the recipient. 
Stem  cells  from  fetal  liver appear  to  populate  adult  erythropoietic tissues 
during development, since spleen colony-forming unit (CFU-S) numbers decline 
as adult tissues are being populated (48) and fetal liver cells have the capacity to 
repopulate stem cell-depleted adults (18, 30, 31) and vice versa (32). However, 
fetal cells must proliferate extensively during the rapid erythropoietic growth 
from the 15- to  16-d fetal mouse to the mature adult. This would deplete stem 
cell proliferative capacities, if they were limited. They would also be depleted by 
the proliferation necessary to produce erythrocytes throughout the adult lifespan. 
Therefore, fetal  liver would show consistently higher long-term repopulating 
abilities than adult marrow if erythropoietic stem cells had limited proliferative 
capacities, and cells from young adults would repopulate better than those from 
old adults. 
In  fact,  the results given  in  Tables  I-III  do not support  these predictions. 
Although exact levels of repopulating ability were affected by the strains used, 
the differences between fetal, young, and old cells were small considering the 
sensitivity of the competitive repopulation assay. The variations were many times 
less than those caused by a single transplantation or sublethal irradiation (17). 
It is possible that fetal liver has a higher repopulating ability than adult marrow, 
but cannot express this in the alien adult marrow hemopoietic environment of 
the recipients. This is unlikely because these two effects would have to counteract 
each other by chance so that the fetal liver and adult marrow compete at roughly 
similar  levels.  A  less  complicated  hypothesis  is  that  the  primitive  stem  cells 
responsible for long-term erythropoietic repopulating ability have similar con- 
centrations in 15- and 16-d fetal livers and in young and old adult marrows. This 
is consistent with findings that stem cell renewal capacity is unchanged from fetal 768  REPOPULATING ABILITIES OF  FETAL AND ADULT CELLS 
life through old age (46), although it contradicts the conclusion from long-term 
marrow cultures that old marrow has a reduced self-renewal capacity (49). 
The  results  described in  Tables  I-III  suggest  that  erythropoietic  stem  cells 
have unlimited proliferative capacities, since they are not reduced by the prolif- 
eration required from  15 d of fetal life through  24-30 mo old adulthood.  This 
is consistent  with recent reports that  repopulating  abilities are not affected by 
repeated treatments  with  hydroxyurea (36) and  that  numbers of cells forming 
macroscopic spleen colonies recover to normal  levels after at least  10 monthly 
treatments with the alkylating agent, triethylenemelamine (TEM) (50). However, 
an alternative hypothesis explaining these results is that most stem cells reserve 
their proliferative capacity, while erythrocytes are produced by descendants of a 
few stem cells at a time (43-46). Recent data (45) supporting this clonal selection 
hypothesis suggest that  10  stem  cells are active over the  40-50-d  erythrocyte 
lifespan,  so  that  each  stem  cell  produces  erythrocytes  for  4-5  d.  This  could 
explain why stem cells do not exhaust limited proliferative capacities during the 
adult lifespan, but still  predicts an advantage of fetal over adult cells, since the 
earliest stem cells would be diluted during growth and development. 
We  tested  this  hypothesis,  incubating  tetraparental  mouse  blood  with  SSS- 
labeled methionine  to label hemoglobin being synthesized in reticulocyte-circu- 
lating erythrocytes produced during the last 3 d. Fig. 2 shows that the fraction 
of the d  hemoglobin type remained nearly constant, although the tetraparental 
mice have stem cells producing one type or the other. Using measured variances 
and  the binomial  distribution,  we calculated  that  62  and  128  stem cells were 
active over each  3-d period,  contrary to the predictions of the clonal selection 
hypothesis (43-46).  However, even these numbers are much too low, because 
the variance was similar in the F~ hybrid control that has only one type of stem 
cell. 
In this report, erythropoietic stem cells were required to recover from two or 
three repeated doses of sublethal irradiation  over more than a year, thus testing 
ultimate  stem  cell  functions  more  rigorously  than  they  had  been  tested  by 
previous studies (18, 30-32).  There was no evidence that repopulating abilities 
were lower in adult mice; in fact, old B6 marrow  tended to repopulate  better 
than equal numbers of B6 fetal liver cells.The least complex hypothesis explaining 
this is that erythropoietic stem cells have unlimited  proliferative capacities and 
are present in similar concentrations in fetal liver and adult marrow. 
Summary 
Erythropoietic repopulating abilities of fetal liver cells and young and old adult 
marrow cells were compared as follows: Equal numbers of cells from a donor of 
each age were mixed  with a  constant  portion  of cells pooled from genetically 
distinguishable  competitors.  These  mixtures  were transplanted  into stem cell- 
depleted recipients, and the proportions of recipient hemoglobin that were donor 
type measured the relative effectiveness of early erythropoietic precursor cells 
from  the  various  donors  (Fig.  1).  At  intervals  of  3-6  mo,  recipients  were 
sublethally irradiated, requiring a new round of competitive repopulation. When 
B6  mice  were  used  as  donors,  with  WBB6F~  competitors  and  recipients,  the 
highest levels of stem cell activity were found using old donors (Tables I,  III). HARRISON, ASTLE, AND  LERNER  769 
This was true even with unirradiated, immune-competent W/W" recipients (Table 
III). When donors and recipients were WBB6F1  hybrids, with B6 competitors, 
fetal cells initially gave higher levels of repopulating ability, and they were similar 
to  the  adult  and  old  marrow  cells  after  400  d  and  after  recovery  from  two 
sublethal  irradiations  (Table  II).  These  effects were  mostly insignificant and 
probably  reflect  small  differences  in  initial  stem  cell  concentrations  that  are 
brought  out by  the  sensitivity of the  competitive repopulation  assay.  Clearly, 
/ultimate  erythropoietic  stem  cell  proliferative  capacities  did  not  decline  as  a 
result  of the  proliferation  required  between  15  d  of fetal  life and  old  age. 
Repopulating  abilities  of  12-d  fetal  liver  cells  were  not  detectable.  We  also 
showed that the proportions of newly synthesized hemoglobins made by the two 
types of stem cells in tetraparental  mice remained nearly constant when tested 
at 3-d intervals over 30 d.  Minimum numbers of stem cells producing erythro- 
cytes over a  single 3-d period were calculated as 62 and  128, but these are too 
low, since variances were similar in the tetraparental mice and in the F1 hybrid 
control.  This contradicts  the  hypothesis that  erythropoietic stem  cells  reserve 
limited proliferative capacities by proliferating one or a few at a time. We suggest 
that erythropoietic stem cells have essentially unlimited proliferative capacities 
and are found in approximately equal concentrations in the primary erythropo- 
ietic organs after 15 or 16 d  of fetal life. 
We thank P. C. Hoppe for preparing the tetraparental mice, D. Ailing and H. Hoffman 
for helpful discussions on the clonal selection hypothesis, and C. Schmidt and J. Delaittre 
for dependable technical assistance. 
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